FDA Examines Process For Approving Ebola Vaccine In Light Of Waning Outbreak

CQ HealthBeat: FDA Weighs Process for Approving Ebola Vaccine
“A Food and Drug Administration advisory panel on Tuesday tackled difficult questions on the development of a vaccine for the Ebola virus although the outbreak, which has killed more than 11,000 people, has subsided. … While that comes as good news for public health, it presents a challenge for drug development and for regulators who now need to look at other data, potentially from animal studies, as it reviews potential vaccines…” (Gustin, 5/12).